(RTTNews) - scPharmaceuticals Inc. (SCPH) Monday reported positive topline results from the pharmacokinetic study of SCP-111 (furosemide), administered via an autoinjector. The study compared the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback